Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Mark Joseph Daly, Ph.D.

Co-Author

This page shows the publications co-authored by Mark Daly and Shamil Sunyaev.
Connection Strength

1.045
  1. Applicability of the Mutation-Selection Balance Model to Population Genetics of Heterozygous Protein-Truncating Variants in Humans. Mol Biol Evol. 2019 08 01; 36(8):1701-1710.
    View in: PubMed
    Score: 0.212
  2. Polygenic adaptation on height is overestimated due to uncorrected stratification in genome-wide association studies. Elife. 2019 03 21; 8.
    View in: PubMed
    Score: 0.207
  3. Reply to 'Selective effects of heterozygous protein-truncating variants'. Nat Genet. 2019 01; 51(1):3-4.
    View in: PubMed
    Score: 0.204
  4. Estimating the selective effects of heterozygous protein-truncating variants from human exome data. Nat Genet. 2017 May; 49(5):806-810.
    View in: PubMed
    Score: 0.181
  5. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012 Apr 04; 485(7397):242-5.
    View in: PubMed
    Score: 0.128
  6. Quantifying unobserved protein-coding variants in human populations provides a roadmap for large-scale sequencing projects. Nat Commun. 2016 10 31; 7:13293.
    View in: PubMed
    Score: 0.044
  7. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A. 2014 Jan 28; 111(4):E455-64.
    View in: PubMed
    Score: 0.036
  8. Extremely low-coverage sequencing and imputation increases power for genome-wide association studies. Nat Genet. 2012 May 20; 44(6):631-5.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.